STOCKHOLM--(BUSINESS WIRE)--As a consequence of that the results of the ChronSeal® study will not be made public until May 27th Kringle Inc. in Japan has given ChronTech Pharma (STO:CTEC) a six months’ extension, i.e. until the 31st of December 2010, of its option to buy back in ownership of the ChronSeal®.
